Primary objective
- To quantify the additional reduction in systolic blood pressure (SBP) and diastolic blood pressure (DBP) of diuretics as second-line therapy in patients with primary hypertension based on cross-over trials.
- To quantify the effects of a second-line diuretic on heart rate (HR).
- To quantify the effects of a second-line diuretic on withdrawals due to adverse effects (WDAE).
This is a protocol.